Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-02-26 @ 12:36 AM
Study NCT ID:
NCT03481634
Status:
COMPLETED
Last Update Posted:
2023-01-30
First Post:
2018-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-13
First Submit QC Date:
None
Study First Post Date:
2018-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-05-27
Results First Submit QC Date:
None
Results First Post Date:
2022-10-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-10-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-01-27
Last Update Post Date:
2023-01-30
Last Update Post Date Type:
ACTUAL